AstraZeneca heart drug wins capitulation in China
LONDON | Thu Nov 29, 2012 6:11am EST LONDON (Reuters) – AstraZeneca has won capitulation for a new heart drug Brilinta in China, an increasingly critical marketplace for a British pharmaceuticals group. China’s State Food and Drug... Read More
